Quarterly Report · 10-Q
Aditxt, Inc.
Quarterly Report
Company context
Aditxt, Inc. (NASDAQ: ADTX) is a public company focused on developing and commercializing health innovation platforms. Ignite Proteomics is currently a 100%-owned subsidiary of Aditxt. Through the proposed business combination, Aditxt expects to unlock value in Ignite at an implied equity value of approximately $150 million, while Ignite is expected to become an independent publicly traded company. Aditxt is expected to continue as a separate Nasdaq-listed public company, subject to continued compliance with Nasdaq listing requirements.
Current securities
Recent company filings
- Entry into a Material Definitive Agreement · Termination of a Material Definitive AgreementOct 15, 2026
- 25-NSE - filed by Nasdaq Stock Market LLC regarding Aditxt, Inc.Oct 7, 2026
- Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingSep 23, 2026
- Other EventsAug 19, 2026
- Entry into a Material Definitive Agreement · Unregistered Sales of Equity SecuritiesJul 17, 2026
Document unavailable
This filing is not currently available in the archive. Read it on SEC EDGAR ↗